116 results on '"Coglianese E"'
Search Results
2. A Blood Conservation Approach to Peri-Transplant Care Informed by Successful Heart Transplantation in a Jehovah’s Witness
3. Pre-Operative INTERMACS Profile as a Predictor of Outcomes in Durable LVAD Patients in the Modern Era
4. (265) Effects of ICU Infection on Durable LVAD Patient Outcomes
5. (275) Early Renal Outcomes Following Cardiac Transplantation Using Organs Procured after Circulatory Death
6. (771) Post-Implant Outcomes in Diabetic vs. Non-Diabetic Durable LVAD Patients
7. The 2023 International Society for Heart and Lung Transplantation Guidelines for Mechanical Circulatory Support: A 10- Year Update
8. Acute 2R Cellular Rejection on Routine Surveillance Endomyocardial Biopsy is Not Associated with Significant Hemodynamic Changes on Right Heart Catheterization
9. Outcomes in Patients with a Centrifugal Flow with Full Magnetic Levitation Left Ventricular Assist Device (CF-FML LVAD) Who Did Not Receive Bridging with a Continuous Heparin Infusion (CHI) After Implantation
10. Intermittent WPW Pattern in a Heart Transplant Recipient with Normal Donor Electrocardiogram
11. Persistent Iron Deficiency and Dysregulated Hepcidin Levels After LVAD Therapy
12. (848) - Heartmate 3 Risk Score Predicts 30-Day Mortality After LVAD Implantation
13. (834) - Markers of Recovery in CF-VAD Patients: Tool for Predicting Outcomes or Not?
14. (471) - Pre-Operative INTERMACS Profile as a Predictor of Outcomes in Durable LVAD Patients in the Modern Era
15. (1092) - Comparison of Hemodynamics in Patients Bridged to Transplant with Temporary vs Durable LVAD
16. (189) - Normalized Hemodynamics at Submaximal Exercise in Patients with Left Ventricular Assist Devices (LVAD)
17. Cellular microparticles as predictive markers for thrombosis and other clinical events in patients with implanted LVADs: OR173
18. Right Ventricular Response to Exercise in LVAD-Supported Patients vs. Heart Failure and Normal Subjects
19. The Burden of Readmissions in the First Year with an LVAD: Predictors and Associated Quality of Life Outcomes
20. Low Peak VO2 and Pulse Pressure Augmentation on Exercise in LVAD Patients with Recovery and Pump Explant
21. Tacrolimus Level Variability in Setting of Gastric Sleeve
22. Effects of Patient Distance from LVAD Implant Center on Outcomes and Quality of Life
23. Home-Based Palliative Care Visits for DT-LVAD Patients
24. (1058) Distinct Pressure-Flow Phenotypes During Exercise in Patients Supported with Left Ventricular Assist Devices (lvad)
25. (643) The New Heart Allocation System Change and DCD Heart Availability: Effects on Durable VAD Patients
26. (632) Effect of UNOS 2018 Heart Transplant Policy Change on LVAD Patients Undergoing Heart Transplantation in an Academic Medical Center
27. Optimal Dosing of Enoxaparin to Achieve Therapeutic Anticoagulation in Heart Transplant Recipients
28. Getting Back on the List: Development of Guidelines for Bariatric Surgery in Patients with LVADs
29. ACE Inhibitor Use is Associated with Reduction in Gastrointestinal Bleeding Events in CF-LVAD Patients
30. Outcomes of Heart Transplantation from Hepatitis C Seropositive Donors: An Updated Analysis of the United Network for Organ Sharing Registry
31. Characteristics of Left Ventricular Assist Device (LVAD) Supported Patients Who Experience Indication Changes during Time on Support
32. Evaluation of Early Allograft Function in Donor HCV-Positive to Recipient HCV-Negative Cardiac Transplantation Managed with Preemptive Direct Acting Antiviral Therapy
33. Preemptive Pan-Genotypic Direct Acting Antiviral Therapy in Donor HCV-Positive to Recipient HCV-Negative Cardiac Transplantation Produces Viral Clearance and is Associated with Favorable Outcomes
34. Characterizing Sex-Specific Baseline Characteristics and Outcomes in Left Ventricular Assist Device (LVAD) Support
35. A Single Center U.S. Experience with the Implementation of Mandatory Patient and Caregiver Pre-Ventricular Assist Device Implantation Education
36. Predictors of Aortic Valve Commissural Fusion in Patients Undergoing Left Ventricular Assist Device Therapy
37. Cellular Microparticles as Predictive Markers for Adverse Events in Patients With Implanted Ventricular Assist Devices
38. Prediction of Hemostatic Dysfunction in Patients Implanted with the HeartMate II LVAD
39. Common genetic variation at the IL1RL1 locus regulates IL-33/ST2 signaling
40. (537) - Cellular Microparticles as Predictive Markers for Adverse Events in Patients With Implanted Ventricular Assist Devices
41. (538) - Predictors of Aortic Valve Commissural Fusion in Patients Undergoing Left Ventricular Assist Device Therapy
42. (656) - Prediction of Hemostatic Dysfunction in Patients Implanted with the HeartMate II LVAD
43. Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study.
44. Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease.
45. Association of novel biomarkers of cardiovascular stress with left ventricular hypertrophy and dysfunction: implications for screening
46. (1126) - A Blood Conservation Approach to Peri-Transplant Care Informed by Successful Heart Transplantation in a Jehovah's Witness.
47. (1092) - Comparison of Hemodynamics in Patients Bridged to Transplant with Temporary vs Durable LVAD.
48. (848) - Heartmate 3 Risk Score Predicts 30-Day Mortality After LVAD Implantation.
49. (834) - Markers of Recovery in CF-VAD Patients: Tool for Predicting Outcomes or Not?
50. (471) - Pre-Operative INTERMACS Profile as a Predictor of Outcomes in Durable LVAD Patients in the Modern Era.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.